BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36948086)

  • 21. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic profile of children with recurrent respiratory infections.
    Bozzetto S; Pirillo P; Carraro S; Berardi M; Cesca L; Stocchero M; Giordano G; Zanconato S; Baraldi E
    Pharmacol Res; 2017 Jan; 115():162-167. PubMed ID: 27888158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precise Metabolomics Reveals a Diversity of Aging-Associated Metabolic Features.
    Tian H; Ni Z; Lam SM; Jiang W; Li F; Du J; Wang Y; Shui G
    Small Methods; 2022 Jul; 6(7):e2200130. PubMed ID: 35527334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct infusion mass spectrometry for metabolomic phenotyping of diseases.
    González-Domínguez R; Sayago A; Fernández-Recamales Á
    Bioanalysis; 2017 Jan; 9(1):131-148. PubMed ID: 27921460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics: A Powerful Tool to Understand the Schizophrenia Biology.
    da Silva Zandonadi F; Dos Santos EAF; Marques MS; Sussulini A
    Adv Exp Med Biol; 2022; 1400():105-119. PubMed ID: 35930229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unveiling Chemical Interactions Between Plants and Fungi Using Metabolomics Approaches.
    de Moraes Pontes JG; da Silva Pinheiro MS; Fill TP
    Adv Exp Med Biol; 2023; 1439():1-20. PubMed ID: 37843803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolome searcher: a high throughput tool for metabolite identification and metabolic pathway mapping directly from mass spectrometry and using genome restriction.
    Dhanasekaran AR; Pearson JL; Ganesan B; Weimer BC
    BMC Bioinformatics; 2015 Feb; 16(1):62. PubMed ID: 25887958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomic studies of Pseudomonas aeruginosa.
    Mielko KA; Jabłoński SJ; Milczewska J; Sands D; Łukaszewicz M; Młynarz P
    World J Microbiol Biotechnol; 2019 Nov; 35(11):178. PubMed ID: 31701321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment.
    Omabe M; Elom S; Omabe KN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):221-229. PubMed ID: 29359679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
    Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
    Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reinvigorated era of bacterial secondary metabolite discovery.
    Sidebottom AM; Carlson EE
    Curr Opin Chem Biol; 2015 Feb; 24():104-11. PubMed ID: 25461728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews.
    Sun H; Zhang A; Yan G; Piao C; Li W; Sun C; Wu X; Li X; Chen Y; Wang X
    Mol Cell Proteomics; 2013 Mar; 12(3):710-9. PubMed ID: 23264353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracting Knowledge from MS Clinical Metabolomic Data: Processing and Analysis Strategies.
    Boccard J; Rudaz S
    Methods Mol Biol; 2018; 1730():371-384. PubMed ID: 29363089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease.
    Wang X; Zhang A; Han Y; Wang P; Sun H; Song G; Dong T; Yuan Y; Yuan X; Zhang M; Xie N; Zhang H; Dong H; Dong W
    Mol Cell Proteomics; 2012 Aug; 11(8):370-80. PubMed ID: 22505723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.